PFE vs RTX: Which Is the Better Buy?
Side-by-side comparison of Pfizer Inc. and RTX Corporation β fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-05.
Pfizer Inc. Β· Healthcare
$26.33
+35.4% upside to fair value
Grade B
VS
RTX Corporation Β· Industrials
$172.90
-21.3% upside to fair value
Grade D
QuantHub Verdict
PFE has more upside to fair value
(+35.4%).
PFE trades at a lower forward P/E
(19.3x).
These are model outputs β not personalized investment advice.
See all research β
Valuation & Fundamentals
| Metric |
PFE |
RTX |
| Current Price |
$26.33 |
$172.90 |
| Fair Value Estimate |
$35.65 |
$136.05 |
| Upside to Fair Value |
+35.4%
|
-21.3%
|
| Market Cap |
$149.8B |
$232.8B |
| Forward P/E |
19.3x
|
32.1x
|
| EV / EBITDA |
12.9x
|
19.2x
|
| Price / Sales |
2.4x
|
2.6x
|
| Price / FCF |
16.5x
|
27.9x
|
| Revenue Growth YoY |
-1.2%
|
+8.7%
|
| Gross Margin |
70.3%
|
20.2%
|
| Operating Margin |
24.7%
|
10.4%
|
| Return on Equity |
8.7%
|
11.2%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
6.06%
|
3.59%
|
| Analyst Consensus |
Hold
|
Buy
|
Investment Thesis
Pfizer Inc. is a leading global pharmaceutical company specializing in drug manufacturing with a strong presence in vaccines, oncology, and primary care. The company benefits from a seasoned leadership team under CEO Albert Bourla, who has driven a strategic transformation focusing on science-driven innovation and portfolio optimization. Despite a high gross margin of 70.3% and solid operating maβ¦
RTX Corporation is a leading aerospace and defense company with a diversified portfolio spanning Pratt & Whitney jet engines, Collins Aerospace avionics, and Raytheon Intelligence & Space defense systems. The company benefits from a strong competitive moat supported by a $271 billion backlog and multi-year contracts, driving consistent revenue growth of 10% in 2025 and 9% in Q1 2026. Earnings groβ¦
Accumulation Zones
| Metric |
PFE |
RTX |
| Zone Low |
$26.74 |
$102.04 |
| Zone High |
$30.30 |
$115.64 |
| In Buy Zone? |
Yes
|
No
|